| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1996) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | B53E3NMY5C |
| Parent Compound: | TIZANIDINE |
Structure
| InChI Key | ZWUKMNZJRDGCTQ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C9H9Cl2N5S |
| Molecular Weight | 290.18 |
| AlogP | 1.72 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 62.2 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 16.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Adrenergic receptor alpha-2 agonist | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Radiculopathy | 3 | D011843 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Brain Injuries | 1 | D001930 | ClinicalTrials |
Related Entries
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 9609 |
| ChEMBL | CHEMBL1200329 |
| EPA CompTox | DTXSID9046990 |
| FDA SRS | B53E3NMY5C |
| Guide to Pharmacology | 7308 |
| KEGG | C07452 |
| PubChem | 114869 |
| SureChEMBL | SCHEMBL41199 |
| ZINC | ZINC19702309 |
CONTENTS